Facebook Retrovirus Detection: The Critical Viral Safety Test for Biopharmaceuticals and Gene Therapies – 14.3% CAGR Driven by Cell Line Testing and Regulatory Compliance
Logo

Retrovirus Detection: The Critical Viral Safety Test for Biopharmaceuticals and Gene Therapies – 14.3% CAGR Driven by Cell Line Testing and Regulatory Compliance

クレジット
Avatar
イラストレーター
Retrovirus Detection: The Critical Viral Safety Test for Biopharmaceuticals and Gene Therapies – 14.3% CAGR Driven by Cell Line Testing and Regulatory Compliance-1
シェア
Ciciの他の作品